Case number 1:18-cv-00648
Sun Pharmaceutical Industries Ltd. et al v. Saptalis Pharmaceuticals, LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 26, 2020 | 186 | Memorandum and Order (14) Docket Text: MEMORANDUM OPINION AND ORDER. Signed by Judge William C. Bryson on 8/26/2020. (nmg) |
| Aug 20, 2020 | 185 | Reply Brief (3) Docket Text: REPLY BRIEF re [180] MOTION to Strike [175] Reply Brief, Plaintiffs' Motion to Strike New Evidence and Arguments Raised in Saptalis' Reply filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Aug 18, 2020 | 183 | Answering Brief in Opposition (17) Docket Text: ANSWERING BRIEF in Opposition re [180] MOTION to Strike [175] Reply Brief, Plaintiffs' Motion to Strike New Evidence and Arguments Raised in Saptalis' Reply filed by Saptalis Pharmaceuticals, LLC.Reply Brief due date per Local Rules is 8/25/2020. (Phillips, John) |
| Aug 18, 2020 | 184 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by Saptalis Pharmaceuticals, LLC re [160] MOTION for Attorney Fees [Defendant Saptalis Pharmaceuticals, LLC's Motion for Exceptional Case Determination and Attorneys' Fees Pursuant to 35 U.S.C. § 285], [180] MOTION to Strike [175] Reply Brief, Plaintiffs' Motion to Strike New Evidence and Arguments Raised in Saptalis' Reply. (Phillips, John) |
| Aug 17, 2020 | 182 | Notice (Other) (2) Docket Text: NOTICE of Plaintiffs' Reply to Defendant's Response to Plaintiffs' Notice of Supplemental Authority by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. re [181] Statement, (Gattuso, Dominick) |
| Aug 14, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 181 mistakenly filed under seal. Counsel to send corrected document. (amf) |
| Aug 13, 2020 | 181 | Statement (4) Docket Text: STATEMENT Defendant Saptalis Pharmaceuticals, LLC's Response to Plaintiffs' Notice of Supplemental Authority (ECF No. 179) by Saptalis Pharmaceuticals, LLC. (Phillips, John) Modified on 8/14/2020 (amf). (Main Document 181 replaced on 8/14/2020) (amf). |
| Aug 4, 2020 | 179 | Notice (Other) (2) Docket Text: NOTICE of Supplemental Authority In Support of Plaintiffs' Answering Brief Opposing Saptalis' Motion for Attorneys' Fees by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. re [168] Answering Brief in Opposition,, [160] MOTION for Attorney Fees [Defendant Saptalis Pharmaceuticals, LLC's Motion for Exceptional Case Determination and Attorneys' Fees Pursuant to 35 U.S.C. § 285] (Attachments: # (1) Exhibit A)(Gattuso, Dominick) |
| Aug 4, 2020 | 179 | Exhibit A (40) |
| Aug 4, 2020 | 180 | Motion to Strike (5) Docket Text: MOTION to Strike [175] Reply Brief, Plaintiffs' Motion to Strike New Evidence and Arguments Raised in Saptalis' Reply - filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Text of Proposed Order [Proposed] Order, # (2) Certificate of Compliance 7.1.1 Certification)(Gattuso, Dominick) |
| Aug 4, 2020 | 180 | Text of Proposed Order [Proposed] Order (1) |
| Aug 4, 2020 | 180 | Certificate of Compliance 7.1.1 Certification (1) |
| Aug 3, 2020 | 177 | Redacted Document (15) Docket Text: REDACTED VERSION of [175] Reply Brief, by Saptalis Pharmaceuticals, LLC. (Haney, Megan) |
| Aug 3, 2020 | 178 | Redacted Document (4) Docket Text: REDACTED VERSION of [176] Declaration, by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit N-V)(Haney, Megan) |
| Aug 3, 2020 | 178 | Exhibit N-V (68) |
| Jul 24, 2020 | 174 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER for Defendant Saptalis Pharmaceuticals, LLC to submit its Reply Brief in Support of its Motion for Attorneys' Fees (D.I. [160]) to July 28, 2020. Signed by Judge William C. Bryson on 7/24/2020. (nmg) |
| Jul 23, 2020 | 171 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendant Saptalis Pharmaceuticals, LLC to submit its Reply Brief in Support of its Motion for Attorneys' Fees (D.I. 160) to July 28, 2020 - filed by Saptalis Pharmaceuticals, LLC. (Haney, Megan) |
| Jul 23, 2020 | 172 | Redacted Document (26) Docket Text: REDACTED VERSION of [168] Answering Brief in Opposition,, to Saptalis' Motion for Attorneys' Fees by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Jul 23, 2020 | 172 | Exhibit Certificate of Service (1) |
| Jul 23, 2020 | 173 | Redacted Document (3) Docket Text: REDACTED VERSION of [169] Declaration, Declaration of Charles B. Klein in Support of Plaintiffs Answering Brief Opposing Saptalis Motion for Attorneys Fees by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit A-H, # (2) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Jul 23, 2020 | 173 | Exhibit A-H (188) |
| Jul 23, 2020 | 173 | Exhibit Certificate of Service (1) |
| Jul 22, 2020 | 170 | Redacted Document (10) Docket Text: REDACTED VERSION of [167] Objections, Plaintiffs Objections to Saptalis' Bill of Costs by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit 1, # (2) Exhibit Certificate of Service)(Gattuso, Dominick) |
| Jul 22, 2020 | 170 | Exhibit 1 (5) |
| Jul 22, 2020 | 170 | Exhibit Certificate of Service (1) |
| Jul 16, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 167 deleted per counsel's request. To be re-filed with correct link. (kmd) |
| Jul 8, 2020 | 163 | Redacted Document (11) Docket Text: REDACTED VERSION of [158] Bill of Costs by Saptalis Pharmaceuticals, LLC. (Haney, Megan) |
| Jul 8, 2020 | 164 | Redacted Document (22) Docket Text: REDACTED VERSION of [159] Declaration by Saptalis Pharmaceuticals, LLC. (Haney, Megan) |
| Jul 8, 2020 | 165 | Redacted Document (25) Docket Text: REDACTED VERSION of [161] Opening Brief in Support, by Saptalis Pharmaceuticals, LLC. (Haney, Megan) |
| Jul 8, 2020 | 166 | Redacted Document (6) Docket Text: REDACTED VERSION of [162] Declaration, by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A - F, # (2) Exhibit G - M)(Haney, Megan) |
| Jul 8, 2020 | 166 | Exhibit A - F (160) |
| Jul 8, 2020 | 166 | Exhibit G - M (102) |
| Jul 2, 2020 | 160 | Motion for Attorney Fees (2) Docket Text: MOTION for Attorney Fees [Defendant Saptalis Pharmaceuticals, LLC's Motion for Exceptional Case Determination and Attorneys' Fees Pursuant to 35 U.S.C. § 285] - filed by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Text of Proposed Order, # (2) Rule 7.1.1 Statement)(Phillips, John) |
| Jul 2, 2020 | 160 | Text of Proposed Order (1) |
| Jul 2, 2020 | 160 | Rule 7.1.1 Statement (1) |
| Jun 2, 2020 | 157 | USCA Order Terminating Appeal (2) Docket Text: USCA Order Terminating Appeal as to [154] Notice of Appeal (Federal Circuit) filed by Sun Pharmaceutical Industries Ltd., Ranbaxy Signature, LLC. USCA Decision: Appeal Voluntarily Dismissed. Each side shall bear its own costs. Issued as a MANDATE. (nmg) |
| Oct 4, 2019 | 156 | USCA Notice of Docketing ROA (3) Docket Text: NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re [154] Notice of Appeal (Federal Circuit) filed by Sun Pharmaceutical Industries Ltd. and Ranbaxy Signature, LLC. USCA Case Number 2020-1011 (nmg) |
| Oct 2, 2019 | N/A | APPEAL - Credit Card Payment (0) Docket Text: APPEAL - Credit Card Payment of $505.00 received re [154] Notice of Appeal (Federal Circuit) filed by Sun Pharmaceutical Industries Ltd., Ranbaxy Signature, LLC. ( Filing fee $505, receipt number 0311-2745729.) (Gattuso, Dominick) |
| Oct 2, 2019 | N/A | Notice of Appeal and Docket Sheet to USCA (0) Docket Text: Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re [154] Notice of Appeal (Federal Circuit). (kmd) |
| Oct 2, 2019 | 154 | Notice of Appeal (Federal Circuit) (2) Docket Text: NOTICE OF APPEAL to the Federal Circuit of [149] Judgment, [143] Memorandum and Order . Appeal filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Oct 2, 2019 | 155 | Appeal Transcript Request (1) Docket Text: TRANSCRIPT REQUEST by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. TRANSCRIPT NOT NEEDED (Gattuso, Dominick) |
| Oct 2, 2019 | 154 | Notice of Appeal* (1) |
| Sep 23, 2019 | 153 | Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove David A. Gerasimow as co-counsel. Reason for request: No longer with Husch Blackwell LLP. (Haney, Megan) |
| Sep 13, 2019 | 152 | Order (1) Docket Text: ORDER granting [151] Stipulation to Extend Time. Signed by Judge William C. Bryson on 9/12/2019. (lak) |
| Sep 12, 2019 | 151 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME time to seek fees and costs to 30 days after the issuance of the mandate of the appellate court or 30 days after the time to appeal expires - filed by Saptalis Pharmaceuticals, LLC. (Phillips, John) |
| Sep 4, 2019 | 149 | Judgment (2) Docket Text: FINAL JUDGMENT in favor of Saptalis Pharmaceuticals, LLC against Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. (SEE JUDGMENT ORDER FOR DETAILS).(CASE CLOSED). Signed by Judge William C. Bryson on 9/3/19. (rwc) |
| Sep 4, 2019 | 150 | Patent/Trademark Report to Commissioner (1) Docket Text: FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,890,957. (Attachments: # (1) Final Judgment)(rwc) |
| Sep 4, 2019 | 150 | Final Judgment (2) |
| Sep 3, 2019 | 148 | Redacted Document (5) Docket Text: REDACTED VERSION of [144] MOTION Unopposed Motion to Redact Memorandum Opinion and Order (D.I. 143) by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Text of Proposed Order)(Haney, Megan) |
| Sep 3, 2019 | 148 | Exhibit A (51) |
| Sep 3, 2019 | 148 | Exhibit B (51) |
| Sep 3, 2019 | 148 | Text of Proposed Order (1) |
| Aug 29, 2019 | 147 | Opening Brief in Support (7) Docket Text: Joint OPENING BRIEF in Support Re Status in Light of Summary Judgment Order of Non-Infringement filed by Saptalis Pharmaceuticals, LLC.Answering Brief/Response due date per Local Rules is 9/12/2019. (Attachments: # (1) Exhibit A)(Phillips, John) |
| Aug 29, 2019 | 147 | Exhibit A (3) |
| Aug 26, 2019 | 145 | Order on Motion for Miscellaneous Relief (1) Docket Text: ORDER granting D.I. [144] [SEALED] Unopposed Motion to Redact Memorandum Opinion and Order (D.I. [143]). Signed by Judge William C. Bryson on 8/26/2019. (nmg) |
| Aug 26, 2019 | 146 | Redacted Document (30) Docket Text: REDACTED VERSION of D.I. [143] MEMORANDUM OPINION AND ORDER re D.I. [69] MOTION for Summary Judgment of Non-Infringement filed by Saptalis Pharmaceuticals, LLC. (nmg) |
| Aug 12, 2019 | 135 | Redacted Document (15) Docket Text: REDACTED VERSION of [126] Answering Brief in Opposition, to Defendant's Motion for Summary Judgment by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) |
| Aug 12, 2019 | 135 | Certificate of Service (1) |
| Aug 12, 2019 | 136 | Redacted Document (43) Docket Text: REDACTED VERSION of [127] Declaration, of Steven Worth Baldwin, PH.D. by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Certificate of Service)(Gattuso, Dominick) |
| Aug 12, 2019 | 136 | Exhibit A (24) |
| Aug 12, 2019 | 136 | Exhibit B (3) |
| Aug 12, 2019 | 136 | Certificate of Service (1) |
| Aug 12, 2019 | 137 | Redacted Document (30) Docket Text: REDACTED VERSION of [128] Declaration, of Michael Mayersohn, Ph.D. by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Certificate of Service)(Gattuso, Dominick) |
| Aug 12, 2019 | 137 | Exhibit A (39) |
| Aug 12, 2019 | 137 | Exhibit B (3) |
| Aug 12, 2019 | 137 | Certificate of Service (1) |
| Aug 12, 2019 | 138 | Redacted Document (19) Docket Text: REDACTED VERSION of [129] Declaration, Second Declaration of Mansoor A. Khan, R.Ph.D. by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit A, # (2) Certificate of Service)(Gattuso, Dominick) |
| Aug 12, 2019 | 138 | Exhibit A (2) |
| Aug 12, 2019 | 138 | Certificate of Service (1) |
| Aug 12, 2019 | 139 | Redacted Document (7) Docket Text: REDACTED VERSION of [130] Declaration, of Bryce A. Cooper by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit 1-11, # (2) Exhibit 12-19, # (3) Exhibit 20-21, # (4) Exhibit 22-37, # (5) Certificate of Service)(Gattuso, Dominick) |
| Aug 12, 2019 | 139 | Exhibit 1-11 (58) |
| Aug 12, 2019 | 139 | Exhibit 12-19 (67) |
| Aug 12, 2019 | 139 | Exhibit 20-21 (59) |
| Aug 12, 2019 | 139 | Exhibit 22-37 (78) |
| Aug 12, 2019 | 139 | Certificate of Service (1) |
| Aug 12, 2019 | 140 | Redacted Document (17) Docket Text: REDACTED VERSION of [131] Opening Brief in Support by Saptalis Pharmaceuticals, LLC. (Phillips, John) |
| Aug 12, 2019 | 141 | Redacted Document (8) Docket Text: REDACTED VERSION of [132] Declaration by Saptalis Pharmaceuticals, LLC. (Phillips, John) |
| Aug 12, 2019 | 142 | Redacted Document (2) Docket Text: REDACTED VERSION of [133] Declaration by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit U, # (2) Exhibit V-X)(Phillips, John) |
| Aug 12, 2019 | 142 | Exhibit U (10) |
| Aug 12, 2019 | 142 | Exhibit V-X (1) |
| Aug 9, 2019 | 134 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Expert Reports of Steven Worth Baldwin, Ph.D., Mansoor A. Khan R. Ph., Ph.D., and Michael Mayersohn, Ph.D. filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Jul 19, 2019 | 124 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-18) filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Jul 19, 2019 | 125 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendant's Second Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 35-39); Plaintiffs' Objections and Responses to Defendant's Third Set of Interrogatories to Plaintiffs (Nos. 11-20); and, Plaintiffs' Second Amended Infringement Claim Chart filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Jul 17, 2019 | 119 | Redacted Document (4) Docket Text: REDACTED VERSION of [114] Letter, regarding Discovery Dispute by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit 1 (Public), # (2) Exhibit 2 (Public), # (3) Exhibit 3 (Under Seal), # (4) Exhibit 4 (Under Seal), # (5) Exhibit 5 (Under Seal), # (6) Exhibit 6 (Under Seal), # (7) Exhibit 7 (Under Seal), # (8) Exhibit 8 (Public))(Gattuso, Dominick) |
| Jul 17, 2019 | 119 | Exhibit 1 (Public) (3) |
| Jul 17, 2019 | 119 | Exhibit 2 (Public) (23) |
| Jul 17, 2019 | 119 | Exhibit 3 (Under Seal) (1) |
| Jul 17, 2019 | 119 | Exhibit 4 (Under Seal) (1) |
| Jul 17, 2019 | 119 | Exhibit 5 (Under Seal) (1) |
| Jul 17, 2019 | 119 | Exhibit 6 (Under Seal) (1) |
| Jul 17, 2019 | 119 | Exhibit 7 (Under Seal) (1) |
| Jul 17, 2019 | 119 | Exhibit 8 (Public) (3) |
| Jul 17, 2019 | 120 | Redacted Document (2) Docket Text: REDACTED VERSION of [116] Letter Response Letter regarding Discovery Dispute by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Jul 17, 2019 | 121 | Redacted Document (2) Docket Text: REDACTED VERSION of [115] Letter, by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Text of Proposed Order, # (7) Averment)(Phillips, John) |
| Jul 17, 2019 | 121 | Exhibit A (6) |
| Jul 17, 2019 | 121 | Exhibit B (1) |
| Jul 17, 2019 | 121 | Exhibit C (5) |
| Jul 17, 2019 | 121 | Exhibit D (10) |
| Jul 17, 2019 | 121 | Exhibit E (4) |
| Jul 17, 2019 | 121 | Text of Proposed Order (1) |
| Jul 17, 2019 | 121 | Averment (1) |
| Jul 17, 2019 | 122 | Redacted Document (4) Docket Text: REDACTED VERSION of [117] Letter, by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Phillips, John) |
| Jul 17, 2019 | 122 | Exhibit A (1) |
| Jul 17, 2019 | 122 | Exhibit B (3) |
| Jul 17, 2019 | 122 | Exhibit C (2) |
| Jul 17, 2019 | 122 | Exhibit D (1) |
| Jul 17, 2019 | 122 | Exhibit E (3) |
| Jul 17, 2019 | 122 | Exhibit F (3) |
| Jul 17, 2019 | 123 | Proposed Order (2) Docket Text: PROPOSED ORDER regarding Discovery Dispute Letters re [119] Redacted Document, by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Averment of Counsel)(Gattuso, Dominick) |
| Jul 17, 2019 | 123 | Averment of Counsel (2) |
| Jul 15, 2019 | 118 | Order (2) Docket Text: MINUTE ORDER - regarding Discovery matters (See Order for details). Signed by Judge William C. Bryson on 7/12/19. (rwc) |
| Jul 10, 2019 | 113 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Saptalis' Amended Initial Disclosures Pursuant to D. Del.'s Default Standard for Discovery; and (2) Saptalis' Amended Rule 26(a)(1)(A) Initial Disclosures filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Jul 9, 2019 | 112 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Saptalis' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Jun 25, 2019 | 111 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Notice of Deposition of Plaintiffs Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Jun 24, 2019 | 109 | Redacted Document (5) Docket Text: REDACTED VERSION of [98] MOTION Defendant Saptalis Pharmaceuticals, LLC's Unopposed Motion to Redact Memorandum Opinion and Order re [97] Memorandum and Order by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Text of Proposed Order, # (2) Exhibit A, # (3) Exhibit B)(Haney, Megan) |
| Jun 24, 2019 | 109 | Text of Proposed Order (1) |
| Jun 24, 2019 | 109 | Exhibit A (19) |
| Jun 24, 2019 | 109 | Exhibit B (2) |
| Jun 24, 2019 | 110 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Saptalis Pharmaceuticals, LLC's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Jun 19, 2019 | 100 | Notice (Other) (2) Docket Text: NOTICE of Plaintiffs' Notice of Deposition of Partha Radadiya on July 15, 2019 at 9:00 a.m. by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. (Gattuso, Dominick) |
| Jun 19, 2019 | 101 | Notice (Other) (2) Docket Text: NOTICE of of Plaintiffs' Deposition of Kishore Aluguvelli on July 18, 2019 at 9:00 a.m. by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. (Gattuso, Dominick) |
| Jun 19, 2019 | 102 | Notice (Other) (2) Docket Text: NOTICE of Plaintiffs' Deposition of Larisa Kuznetsova on July 11, 2019 at 9:00 a.m. by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. (Gattuso, Dominick) |
| Jun 19, 2019 | 103 | Notice (Other) (2) Docket Text: NOTICE of Plaintiffs' Deposition of Manaswini Garimella on July 17, 2019 at 9:00 a.m. by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. (Gattuso, Dominick) |
| Jun 19, 2019 | 104 | Notice (Other) (2) Docket Text: NOTICE of Plaintiffs' Deposition of Yuliya Levintova on July 10, 2019 at 9:00 a.m. by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. (Gattuso, Dominick) |
| Jun 19, 2019 | 105 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-18) filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Jun 19, 2019 | 106 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Saptalis Pharmaceuticals, LLC's Second Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 35-39); and (2) Defendant Saptalis Pharmaceuticals, LLC's Third Set of Interrogatories to Plaintiffs (Nos. 11-20) filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Jun 19, 2019 | 107 | Order (1) Docket Text: ORDER - the Court having considered Defendant Saptalis Pharmaceuticals, LLCs Unopposed Motion to Redact Memorandum Opinion and Order (Dkt. No. [98]), hereby ORDERS that the Motion is GRANTED. The Court will file a redacted version of the Memorandum Opinion and Order, Dkt. No. [97]. In addition to redacting the language proposed by the defendant, the Court will also remove the first footnote of the Memorandum Opinion and Order, Dkt. No. [97], which pertains to this issue of confidentiality. Signed by Judge William C. Bryson on 6/19/2019. (amf) |
| Jun 19, 2019 | 108 | Memorandum and Order (18) Docket Text: REDACTED MEMORANDUM AND ORDER. Signed by Judge William C. Bryson on 6/10/2019. (amf) |
| May 20, 2019 | 96 | Letter (1) Docket Text: Letter to The Honorable William C. Bryson from John C. Phillips, Jr. regarding supplemental authority - re [69] MOTION for Summary Judgment of Non-Infringement. (Attachments: # (1) Exhibit 1)(Phillips, John) |
| May 20, 2019 | 96 | Exhibit 1 (17) |
| May 10, 2019 | 95 | Letter (1) Docket Text: Letter to The Honorable William C. Bryson from Dominick T. Gattuso, Esquire regarding Response to Saptalis Pharmaceuticals, LLC's submission of supplemental authority in support of its motion for summary judgment (D.I. 94) - re [94] Letter,. (Gattuso, Dominick) |
| May 9, 2019 | 94 | Letter (1) Docket Text: Letter to The Honorable William C. Bryson from John C. Phillips, Jr. regarding supplemental authority in support of Saptalis' motion for summary judgment of non-infringement - re [69] MOTION for Summary Judgment of Non-Infringement. (Attachments: # (1) Exhibit 1)(Phillips, John) |
| May 9, 2019 | 94 | Exhibit 1 (17) |
| Mar 29, 2019 | 91 | Stipulation (2) Docket Text: STIPULATION to Extend Certain Deadlines in the Scheduling Order by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Mar 29, 2019 | 92 | Stipulation and Order (2) Docket Text: STIPULATION AND ORDER, The deadline for completion of document production set forth in paragraph 3.b. shall be extended from May 1, 2019 to and including June 21, 2019. The deadline for the completion of fact discovery set forth in paragraph 3.a. shall be extended from July 12, 2019 to and including July 19, 2019. No other dates or terms set forth in the Scheduling Order shall be amended absent an order of this Court. Signed by Judge William C. Bryson on 3/29/2019. (nmg) |
| Mar 15, 2019 | 89 | Redacted Document (29) Docket Text: REDACTED VERSION of [87] Reply Brief by Saptalis Pharmaceuticals, LLC. (Phillips, John) |
| Mar 15, 2019 | 90 | Redacted Document (3) Docket Text: REDACTED VERSION of [88] Declaration, by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibits S-T)(Phillips, John) |
| Mar 15, 2019 | 90 | Exhibits S-T (1) |
| Mar 1, 2019 | 83 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Mansoor A. Khan (Amended) on March 4, 2019 filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Mar 1, 2019 | 84 | Redacted Document (30) Docket Text: REDACTED VERSION of [79] Answering Brief in Opposition, by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Mar 1, 2019 | 85 | Redacted Document (4) Docket Text: REDACTED VERSION of [80] Declaration, (Claire Fundakowski) by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit A - P)(Gattuso, Dominick) |
| Mar 1, 2019 | 85 | Exhibit A - P (177) |
| Mar 1, 2019 | 86 | Redacted Document (33) Docket Text: REDACTED VERSION of [81] Declaration, (Mansoor A. Khan, R.Ph., Ph.D.) by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit 1 - 2)(Gattuso, Dominick) |
| Mar 1, 2019 | 86 | Exhibit 1 - 2 (76) |
| Feb 28, 2019 | 82 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Mansoor A. Khan on March 2, 2019 filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Feb 11, 2019 | 78 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Saptalis Pharmaceuticals, LLC's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-17); and (2) Defendant's Objections and Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 32-46) filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Feb 4, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Claire A. Fundakowski for Sun Pharmaceutical Industries Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Feb 1, 2019 | 74 | Order on Motion to Appear Pro Hac Vice (1) Docket Text: ORDER granting D.I. [73] MOTION for Pro Hac Vice Appearance of Attorney Claire A. Fundakowski. Signed by Judge William C. Bryson on 2/1/2019. (nmg) |
| Feb 1, 2019 | 75 | Redacted Document (30) Docket Text: REDACTED VERSION of [70] Opening Brief in Support by Saptalis Pharmaceuticals, LLC. (Phillips, John) |
| Feb 1, 2019 | 76 | Redacted Document (5) Docket Text: REDACTED VERSION of [71] Declaration,, by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R)(Phillips, John) |
| Feb 1, 2019 | 76 | Exhibit A (11) |
| Feb 1, 2019 | 76 | Exhibit B (2) |
| Feb 1, 2019 | 76 | Exhibit C (10) |
| Feb 1, 2019 | 76 | Exhibit D (10) |
| Feb 1, 2019 | 76 | Exhibit E (11) |
| Feb 1, 2019 | 76 | Exhibit F (43) |
| Feb 1, 2019 | 76 | Exhibit G (31) |
| Feb 1, 2019 | 76 | Exhibit H (3) |
| Feb 1, 2019 | 76 | Exhibit I (4) |
| Feb 1, 2019 | 76 | Exhibit J (14) |
| Feb 1, 2019 | 76 | Exhibit K (9) |
| Feb 1, 2019 | 76 | Exhibit L (7) |
| Feb 1, 2019 | 76 | Exhibit M (3) |
| Feb 1, 2019 | 76 | Exhibit N (3) |
| Feb 1, 2019 | 76 | Exhibit O (3) |
| Feb 1, 2019 | 76 | Exhibit P (6) |
| Feb 1, 2019 | 76 | Exhibit Q (8) |
| Feb 1, 2019 | 76 | Exhibit R (2) |
| Feb 1, 2019 | 77 | Redacted Document (22) Docket Text: REDACTED VERSION of [72] Declaration by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Phillips, John) |
| Feb 1, 2019 | 77 | Exhibit 1 (16) |
| Feb 1, 2019 | 77 | Exhibit 2 (2) |
| Jan 31, 2019 | 73 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Claire A. Fundakowski - filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Jan 25, 2019 | 69 | Motion for Summary Judgment (2) Docket Text: MOTION for Summary Judgment of Non-Infringement - filed by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Text of Proposed Order)(Phillips, John) |
| Jan 25, 2019 | 69 | Text of Proposed Order (2) |
| Jan 14, 2019 | 68 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Amended Initial Infringement Claim Chart [CONFIDENTIAL INFORMATION - SUBJECT TO PROTECTIVE ORDER] filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Jan 11, 2019 | 67 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories (Nos. 1-17), and Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 32-46) filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Jan 10, 2019 | 66 | Redacted Document (5) Docket Text: REDACTED VERSION of [62] Letter by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit 1-3)(Gattuso, Dominick) |
| Jan 10, 2019 | 66 | Exhibit 1-3 (35) |
| Jan 4, 2019 | 64 | Order (2) Docket Text: MINUTE ORDER: On January 4, 2019, the Court held a telephonic hearing on Saptalis's request to modify the Scheduling Order. The Court made the following oral rulings - 1. The Court granted Saptalis's request to modify the Scheduling Order ([39]) to replace the Claim Construction Briefing and Hearing with briefing and a hearing on a motion for summary judgment based on non-infringement; 2. The Court withdrew sections 9, 10, and 12(a) of the scheduling order; 3. Saptalis's Opening Brief due January 25, 2019, Sun's Response Brief due February 22, 2019, Saptalis's Reply Brief due March 8, 2019, and Summary Judgment Hearing (if necessary) scheduled for April 9, 2019; and 4. Based on the Courts granting of Saptalis's request, Saptalis has formally waived its invalidity positions. Signed by Judge William C. Bryson on 1/4/2019. (ceg) |
| Jan 4, 2019 | 65 | Redacted Document (5) Docket Text: REDACTED VERSION of [61] Letter by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Proposed Order)(Phillips, John) |
| Jan 4, 2019 | 65 | Exhibit 1 (10) |
| Jan 4, 2019 | 65 | Exhibit 2 (7) |
| Jan 4, 2019 | 65 | Proposed Order (2) |
| Jan 3, 2019 | 63 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Aaron M. Nelson on behalf of Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. (Nelson, Aaron) |
| Dec 18, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Don J. Mizerk and David A. Gerasimow for Saptalis Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Dec 14, 2018 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's Objections and Responses to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-31) filed by Saptalis Pharmaceuticals, LLC.(Haney, Megan) |
| Dec 13, 2018 | 58 | Motion for Leave to Appear Pro Hac Vice (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Don J. Mizerk and David A. Gerasimow - filed by Saptalis Pharmaceuticals, LLC. (Attachments: # (1) Certification of Don J. Mizerk, # (2) Certification of David A. Gerasimow)(Haney, Megan) |
| Dec 13, 2018 | 58 | Certification of Don J. Mizerk (1) |
| Dec 13, 2018 | 58 | Certification of David A. Gerasimow (1) |
| Dec 13, 2018 | 59 | Order on Motion to Appear Pro Hac Vice (1) Docket Text: ORDER granting [58] Motion to Appear Pro Hac Vice of Attorney Don J. Mizerk and David A. Gerasimow. Signed by Judge William C. Bryson on 12/13/2018. (ceg) |
| Dec 11, 2018 | 57 | Notice of Substitution of Counsel (1) Docket Text: NOTICE OF SUBSTITUTION OF COUNSEL re Saptalis Pharmaceuticals, LLC: Entry of appearance of attorney John C. Phillips, Jr. Attorney Kenneth L. Dorsney, Steven D. Roth, David Galluzo, Thomas Vetter terminated. (Phillips, John) |
| Dec 10, 2018 | 55 | Order Setting Mediation Conferences (7) Docket Text: ORDER Setting Mediation Conferences: A Mediation Conference is set for 3/6/2019 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 12/10/18. (cak) |
| Dec 10, 2018 | 56 | Claim Construction Chart (2) Docket Text: CLAIM Construction Chart by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Gattuso, Dominick) |
| Dec 10, 2018 | 56 | Exhibit A (4) |
| Dec 10, 2018 | 56 | Exhibit B (12) |
| Dec 10, 2018 | 56 | Exhibit C (6) |
| Dec 10, 2018 | 56 | Exhibit D (8) |
| Dec 10, 2018 | 56 | Exhibit E (7) |
| Dec 10, 2018 | 56 | Exhibit F (21) |
| Dec 7, 2018 | 54 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Interrogatories to Plaintiffs (No. 10) [CONFIDENTIAL INFORMATION - SUBJECT TO PROTECTIVE ORDER] filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Dec 6, 2018 | 53 | Order (1) Docket Text: ORDER GRANTING D.I. [52] STIPULATION TO EXTEND TIME to file a Joint Claim Construction Chart to December 10, 2018 filed by Ranbaxy Signature, LLC. Signed by Judge William C. Bryson on 12/6/2018. (nmg) |
| Dec 5, 2018 | 52 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file a Joint Claim Construction Chart to December 10, 2018 - filed by Ranbaxy Signature, LLC. (Gattuso, Dominick) |
| Nov 27, 2018 | 49 | Order (1) Docket Text: ORDER: The hearing on claim construction in this case, currently scheduled for April 3, 2019, will be held instead at 10:00 a.m. on Tuesday, April 9, 2019, in Courtroom 4A, J. Caleb Boggs Federal Building (*see Order for further details). Signed by Judge William C. Bryson on 11/27/2018. (ceg) |
| Nov 27, 2018 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Saptalis Pharmaceuticals, LLC's Claim Terms and Proposed Constructions filed by Saptalis Pharmaceuticals, LLC.(Dorsney, Kenneth) |
| Nov 27, 2018 | 51 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Proposed Constructions for Claim Terms of U.S. Patent No. 6,890,957 filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Nov 19, 2018 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Invalidity Contentions filed by Saptalis Pharmaceuticals, LLC.(Dorsney, Kenneth) |
| Nov 15, 2018 | 46 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 17, 2018. Date of Expiration of Patent: August 7, 2021.Thirty Month Stay Deadline: 9/17/2020. (Gattuso, Dominick) |
| Nov 15, 2018 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Amended Objection and Response to Interrogatory No. 3 of Defendant's First Set of Interrogatories to Plaintiffs filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Nov 14, 2018 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-31) filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Nov 7, 2018 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Saptalis Pharmaceuticals, LLC's Second Set of Interrogatories to Plaintiffs (No. 10) filed by Saptalis Pharmaceuticals, LLC.(Dorsney, Kenneth) |
| Nov 5, 2018 | 43 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 11/19/2018 at 11:30 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 11/5/18. (cak) |
| Oct 24, 2018 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation (cak) |
| Oct 24, 2018 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Saptalis' Rule 26(a)(1) Initial Disclosures; and (2) Saptalis' Paragraph 3 Disclosures filed by Saptalis Pharmaceuticals, LLC.(Dorsney, Kenneth) |
| Oct 24, 2018 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature LLC's Rule 26(a)(1) Initial Disclosures, and 2) Plaintiffs Sun Pharmaceutical Industries, Ltd., and Ranbaxy Signature LLC's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Oct 18, 2018 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Claim Chart [CONFIDENTIAL INFORMATION - SUBJECT TO PROTECTIVE ORDER] filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Oct 15, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (WCB) after the case number on all documents filed. (rjb) |
| Oct 10, 2018 | 39 | Scheduling Order (9) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 5/1/2019. Amended Pleadings due by 5/1/2019. Discovery due by 7/12/2019. Claim Construction Opening Brief due by 1/10/2019. Claim Construction Answering Brief due by 2/8/2019. Claim Construction Reply Brief due by 2/22/2019. Claim Construction Surreply Brief due by 3/8/2019. The parties are directed to paragraph 9 of the Scheduling Order for the corrected word limit for claim construction briefing. Joint Claim Construction Brief filed by 3/13/2019. A Markman Hearing is set for 4/3/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 1/28/2020 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 2/18/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 10/10/2018. (nmf) |
| Oct 4, 2018 | 38 | Proposed Order (9) Docket Text: PROPOSED ORDER // [Proposed] Revised Scheduling Order by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Letter to the Honorable Colm F. Connolly from Dominick T. Gattuso)(Gattuso, Dominick) |
| Oct 4, 2018 | 38 | Letter to the Honorable Colm F. Connolly from Dominick T. Gattuso (1) |
| Sep 28, 2018 | 37 | Order (2) Docket Text: ORDER re [36] Proposed Scheduling Order. IT IS ORDERED that in light of the reassignment of this case, the Court HEREBY ORDERS that the prior referral to Chief Magistrate Judge Mary Pat Thynge is withdrawn, with the exception that any referral to a Magistrate Judge for ADR shall remain in place. IT IS FURTHER ORDERED that the parties shall incorporate the deadlines and discovery limitations agreed upon in their proposed scheduling order filed at D.I. [36] into a proposed revised scheduling order that is based on the Court's "Rule 16 Scheduling Order for Patent Cases" available on the Court's website. The parties shall include in the proposed revised scheduling order the language currently included in paragraph 10 of their proposed scheduling order that states that no case dispositive motions shall be filed in this action without prior authorization from the Court. The parties should assume that the Court will not grant such leave as the Court will be the fact finder at trial. Signed by Judge Colm F. Connolly on 9/28/2018. (nmf) |
| Sep 27, 2018 | 36 | Proposed Order (11) Docket Text: PROPOSED ORDER // Parties' Proposed Scheduling Order by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Letter to the Honorable Mary Pat Thynge)(Gattuso, Dominick) |
| Sep 27, 2018 | 36 | Letter to the Honorable Mary Pat Thynge (1) |
| Sep 24, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: DI 35 is the transcript of the 8/17/18 scheduling teleconference with Judge Thynge (cak) |
| Sep 24, 2018 | 35 | Transcript (42) Docket Text: Official Transcript of Scheduling Teleconference held on 8/17/18 before Judge Thynge. Court Reporter/Transcriber Stacey Vickers,Telephone number Hawkins Reporting. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/27/2018. Redacted Transcript Deadline set for 10/9/2018. Release of Transcript Restriction set for 12/5/2018. (cak) Modified on 9/24/2018 (cak). |
| Sep 21, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: DI 35 was removed from the docket since it was a duplicate of the Transcript filed at DI 34. (cak) |
| Sep 20, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [28] Oral Order Setting Teleconference. The transcript of the 9/12/18 teleconference with Judge Thynge shall serve as the order of the court in this matter. Ordered by Judge Mary Pat Thynge on 9/20/18. (cak) |
| Sep 20, 2018 | 34 | Transcript (36) Docket Text: Official Transcript of Teleconference held on 9/12/18 before Judge Thynge. Court Reporter/Transcriber Taneah Carroll. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 10/11/2018. Redacted Transcript Deadline set for 10/22/2018. Release of Transcript Restriction set for 12/19/2018. (cak) |
| Sep 18, 2018 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Saptalis Pharmaceutials, LLC's Core Technical Documents filed by Saptalis Pharmaceuticals, LLC.(Dorsney, Kenneth) |
| Sep 18, 2018 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Sun Pharmaceutical Industries, Ltd. and Ranbaxy Signature LLC's Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Sep 14, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: DI 31 removed from the docket since it related to mediation and should not have been docketed. (cak) |
| Sep 12, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mary Pat Thynge - Telephone Conference held on 9/12/2018. Taneah Carroll - Court Reporter (cak) Modified on 9/20/2018 (cak). |
| Sep 11, 2018 | 30 | Letter (3) Docket Text: Letter to The Honorable Mary Pat Thynge from Dominick T. Gattuso regarding response to Defendant Saptalis Pharmaceuticals LLC's September 7, 2018 Letter - re [29] Letter. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Gattuso, Dominick) |
| Sep 11, 2018 | 30 | Exhibit A (4) |
| Sep 11, 2018 | 30 | Exhibit B (4) |
| Sep 11, 2018 | 30 | Exhibit C (3) |
| Sep 7, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Teleconference: A teleconference is scheduled for Wednesday, September 12, 2018 at 12:30 p.m. Eastern to discuss the scheduling order addressed during the scheduling conference of August 17, 2018. Counsel are relieved of their obligation to file the scheduling order on Friday, September 7, 2018. Counsel shall arrange for a court reporter to be present in chambers. Ordered by Judge Mary Pat Thynge on 9/7/2018. (fms) |
| Sep 7, 2018 | 29 | Letter (5) Docket Text: Letter to Chief Magistrate Judge Mary Pat Thynge from Kenneth L. Dorsney regarding the Court's September 7, 2018 Oral Order and Scheduling Issues - re [28] Oral Order,, Order Setting Teleconference,. (Dorsney, Kenneth) |
| Sep 5, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Aug 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Aug 27, 2018 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Plaintiffs' Objections and Responses to Defendant's First Set of Interrogatories to Plaintiffs (Nos. 1-9) [CONFIDENTIAL INFORMATION - SUBJECT TO PROTECTIVE ORDER]; and 2) Plaintiffs' Objections and Responses to Defendant's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-34) filed by Ranbaxy Signature, LLC.(Gattuso, Dominick) |
| Aug 24, 2018 | 26 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Appearance of Samuel S. Park by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. (Gattuso, Dominick) |
| Aug 17, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Mary Pat Thynge - Telephone Scheduling Conference held on 8/17/2018; Counsel shall file a Final Scheduling Order by 9/7/18; Counsel shall file a joint letter by 9/14/18 advising the court concerning mediation referral. ATTENDEES: PLTFF - D. Gattuso, Esq.; B. Cooper, Esq.; DEFT - K. Dorsney, Esq.; S. Roth, Esq.; CLERK - Kincaid. (Court Reporter Stacey - Hawkins Reporting.) (kjk) |
| Aug 10, 2018 | 25 | Proposed Order (11) Docket Text: PROPOSED ORDER // Proposed Scheduling Order by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Letter to the Honorable Mary Pat Thynge Transmitting Proposed Scheduling Order)(Gattuso, Dominick) |
| Aug 10, 2018 | 25 | Letter to the Honorable Mary Pat Thynge Transmitting Proposed Scheduling Order (1) |
| Aug 6, 2018 | 24 | Protective Order (22) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Mary Pat Thynge on 8/6/2018. (fms) |
| Aug 3, 2018 | 23 | Proposed Order (22) Docket Text: PROPOSED ORDER // Stipulated Protective Order by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Jul 26, 2018 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Saptalis Pharmaceuticals, LLC's First Set of Interrogatories to Plaintiffs (Nos. 1-9); (2) Defendant Saptalis Pharmaceuticals, LLC's First Set of Requests for Production to Plaintiffs (Nos. 1-34) filed by Saptalis Pharmaceuticals, LLC.(Dorsney, Kenneth) |
| Jun 28, 2018 | N/A | Oral Order (0) Docket Text: ORAL ORDER Setting Rule 16 Scheduling Teleconference: A scheduling teleconference pursuant to Fed. R. Civ. P. 16(b) will be held on 8/17/18 at 11:00 a.m. Eastern Time with Chief Magistrate Judge Mary Pat Thynge. Plaintiffs' counsel shall initiate the teleconference call. The parties are required to prepare for the teleconference by conferring on all matters under Rule 16 and D. Del. LR 16 and shall submit a proposed Scheduling Order to the Court no later than 8/10/18. Judge Thynge's form scheduling order has been revised as of 6/27/2018 and is posted at http://www.ded.uscourts.gov (see Chambers, Judge Thynge, Forms). If the parties have any suggestions or modifications to the standard Scheduling Order, they may be included in the proposed order for consideration by the Court. If any disputed issue exists regarding the proposed Scheduling Order, it shall be noted therein, along with the parties proposed language on the issue for consideration by the Court. Local counsel are reminded of their obligations to inform out-of-state counsel of this Order. To avoid the imposition of sanctions, counsel shall advise the Court immediately of any problems regarding compliance with this Order. Signed by Judge Mary Pat Thynge on 6/28/18.(fms) |
| Jun 26, 2018 | 20 | Notice (Other) (1) Docket Text: NOTICE of Withdrawal of Motion to Transfer to Eastern District of New York by Saptalis Pharmaceuticals, LLC re [11] MOTION to Transfer Case to Eastern District of New York (Dorsney, Kenneth) |
| Jun 18, 2018 | 18 | Letter (2) Docket Text: Letter to The Honorable Mary Pat Thynge from Dominick T. Gattuso regarding pending motion to transfer to the Eastern District of New York. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Gattuso, Dominick) |
| Jun 18, 2018 | 18 | Exhibit A (4) |
| Jun 18, 2018 | 18 | Exhibit B (16) |
| Jun 18, 2018 | 18 | Exhibit C (3) |
| Jun 18, 2018 | 19 | Letter (4) Docket Text: Letter to The Honorable Mary Pat Thynge from Kenneth L. Dorsney regarding response to Plaintiffs' June 18, 2018 Letter regarding pending Motion to Transfer to the Eastern District of New York - re [18] Letter. (Dorsney, Kenneth) |
| Jun 12, 2018 | 17 | Answer to Counterclaim (16) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim Plaintiffs' Answer to Saptalis Pharmaceuticals, LLC's Counterclaims by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Jun 8, 2018 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Replaced the brief at DI 16 with a corrected copy at the request of counsel. (cak) |
| Jun 8, 2018 | 16 | Reply Brief (5) Docket Text: REPLY BRIEF re [11] MOTION to Transfer Case to Eastern District of New York filed by Saptalis Pharmaceuticals, LLC. (Dorsney, Kenneth) (Main Document 16 replaced on 6/8/2018) (cak). |
| Jun 5, 2018 | 14 | Response to Motion (8) Docket Text: RESPONSE to Motion re [11] MOTION to Transfer Case to Eastern District of New York filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Jun 5, 2018 | 15 | Declaration (3) Docket Text: DECLARATION re [14] Response to Motion in opposition to Defendant's Motion to Transfer by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C)(Gattuso, Dominick) |
| Jun 5, 2018 | 15 | Exhibit A (23) |
| Jun 5, 2018 | 15 | Exhibit B (26) |
| Jun 5, 2018 | 15 | Exhibit C (4) |
| May 23, 2018 | N/A | Order on Motion to Appear Pro Hac Vice (0) Docket Text: SO ORDERED granting [13] Motion to Appear Pro Hac Vice of Attorney Steven Roth - filed by Saptalis Pharmaceuticals, LLC. Signed by Judge Mary Pat Thynge on 5/23/18. (cak) |
| May 22, 2018 | 9 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint, with Jury Demand , COUNTERCLAIM against All Plaintiffs by Saptalis Pharmaceuticals, LLC.(Dorsney, Kenneth) |
| May 22, 2018 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Saptalis Pharmaceuticals, LLC. (Dorsney, Kenneth) |
| May 22, 2018 | 11 | Motion to Transfer Case (6) Docket Text: MOTION to Transfer Case to Eastern District of New York - filed by Saptalis Pharmaceuticals, LLC. Motions referred to Mary Pat Thynge.(Dorsney, Kenneth) |
| May 22, 2018 | 12 | Declaration (10) Docket Text: DECLARATION re [11] MOTION to Transfer Case to Eastern District of New York (Declaration of Tatiana Akimova) by Saptalis Pharmaceuticals, LLC. (Dorsney, Kenneth) |
| May 22, 2018 | 13 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven Roth - filed by Saptalis Pharmaceuticals, LLC. Motions referred to Mary Pat Thynge.(Dorsney, Kenneth) |
| May 11, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Bryce A. Cooper, Charles B. Klein, and Samuel S. Park for Sun Pharmaceutical Industries Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| May 7, 2018 | N/A | Order on Motion to Appear Pro Hac Vice (0) Docket Text: SO ORDERED granting [8] Motion to Appear Pro Hac Vice of Attorney Charles B. Klein, Samuel S. Park, Bryce A. Cooper - filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd. Signed by Judge Mary Pat Thynge on 5/7/18. (cak) |
| May 2, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Vacant Judgeship (2017). Please include initials of VAC after the case number on all documents filed. (rjb) |
| May 2, 2018 | N/A | Case Referred to Magistrate Judge (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge. (This matter has been assigned to the Vacant Judgeship and referred to a Magistrate Judge for handling through case-dispositive motions. The Magistrate Judge has full authority permitted by law to manage this matter, including entering schedules through trial, deciding non-dispositive matters and making recommendations as to the resolution of dispositive matters. Litigants and counsel are reminded that they have the option of consenting to the Magistrate Judge to handle the case in full, including trial, or consenting to having a particular motion resolved by the Magistrate Judge.) Motion referred to Mary Pat Thynge.(rjb) |
| May 2, 2018 | N/A | Remark (0) Docket Text: ***NOTE: If the parties jointly consent to Chief Magistrate Judge Thynges jurisdiction to conduct all proceedings in this case, then the Pretrial Conference and Trial will be presided over by Judge Thynge consistent with 28 U.S.C. § 636. Otherwise, in accordance with the District Court's procedures for "Assignment of Cases to Visiting Judges" (issued May 26, 2017 and available on the District Court's website), upon the filing of a case-dispositive motion (e.g., a motion to dismiss, a motion for judgment on the pleadings, a motion for summary judgment, or initiation of the claim construction process in a patent case), VAC cases will be reassigned to a visiting District Judge, and any further dates in the Scheduling Order, including the Pretrial Conference and Trial dates, may be adjusted dependent on the availability of the visiting District Judge. (cak) |
| May 2, 2018 | 8 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Samuel S. Park, Bryce A. Cooper - filed by Ranbaxy Signature, LLC, Sun Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| May 1, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Sun Pharmaceutical Industries Ltd., Ranbaxy Signature, LLC. Saptalis Pharmaceuticals, LLC served on 5/1/2018, answer due 5/22/2018. (Gattuso, Dominick) |
| Apr 30, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Saptalis Pharmaceuticals, LLC on 4/30/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar) |
| Apr 30, 2018 | 1 | Exhibit A (11) |
| Apr 30, 2018 | 1 | Civil Cover Sheet (2) |
| Apr 30, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) |
| Apr 30, 2018 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: March 17, 2018. Date of Expiration of Patent: September 14, 2023.Thirty Month Stay Deadline: 9/17/2020. (sar) |
| Apr 30, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,890,957. (sar) |
| Apr 30, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Holdings USA, Inc. for Ranbaxy Signature, LLC filed by Ranbaxy Signature, LLC. (sar) |
| Apr 30, 2018 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sun Pharmaceutical Industries Ltd.. (sar) |
| Apr 30, 2018 | 1 | Complaint* (1) |
